Skip to content

Rifampicin levels strongly reduced in patients with TB and diabetes

Resistance testing may be useful for some with 'undetectable' viral loads

International drug purchase fund kicks off with support for paediatric & second-line HIV treatment

Roche announces transfer of protease inhibitor know-how to 3 African companies

Home-based AIDS care program achieves good adherence and response to antiretroviral therapy (ART) in rural Uganda

HIV-positive patients have increased risk of side-effects to key drugs used to treat opportunistic infections

Recombinant human growth hormone reduces visceral fat in two randomised studies

One-in-six interrupt treatment within two years of initiating ART

Studies suggest possible benefits of treating primary HIV infection